Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2017

01-06-2017 | Original Article

Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn’s Disease

Authors: Jong Wook Kim, Ho-Su Lee, Byong Duk Ye, Suk-Kyun Yang, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim

Published in: Digestive Diseases and Sciences | Issue 6/2017

Login to get access

Abstract

Background

Incidence of and risk factors for intestinal free perforation (FP) in patients with Crohn’s disease (CD) are not established.

Aim

To establish rate of and risk factors for FP in a large cohort of CD patients.

Methods

Medical records of CD patients who visited Asan Medical Center from June 1989 to December 2012 were reviewed. After matching the FP patients to controls (1:4) by gender, year, and age at CD diagnosis, and disease location, their clinical characteristics were compared using conditional logistic regression analysis.

Results

Among 2043 patients who were included in our study cohort, 44 patients (2.15%) developed FP over a median follow-up period of 79.8 months (interquartile range 37.3–124.6), with an incidence of 3.18 per 1000 person-years [95% confidence interval (CI) 2.37–4.28]. All 44 patients underwent emergency surgery, and eight patients underwent reoperation within 12 months (8/44, 18.2%). Multivariable-adjusted analysis revealed that anti-TNF therapy [odds ratio (OR), 3.73; 95% CI 1.19–11.69; p = 0.024] was associated with an increased risk of FP.

Conclusions

The incidence of FP in a large cohort of Korean CD patients was 2.15%, which was similar to that in Western reports. Anti-TNF therapy could be risk factors for FP.
Literature
1.
go back to reference Freeman HJ. Spontaneous free perforation of the small intestine in Crohn’s disease. Can J Gastroenterol. 2002;16:23–27.CrossRefPubMed Freeman HJ. Spontaneous free perforation of the small intestine in Crohn’s disease. Can J Gastroenterol. 2002;16:23–27.CrossRefPubMed
2.
go back to reference Abascal J, Diaz-Rojas F, Jorge J, et al. Free perforation of the small bowel in Crohn’s disease. World J Surg. 1982;6:216–220.CrossRefPubMed Abascal J, Diaz-Rojas F, Jorge J, et al. Free perforation of the small bowel in Crohn’s disease. World J Surg. 1982;6:216–220.CrossRefPubMed
3.
go back to reference Greenstein AJ, Aufses AH Jr. Differences in pathogenesis, incidence and outcome of perforation in inflammatory bowel disease. Surg Gynecol Obstet. 1985;160:63–69.PubMed Greenstein AJ, Aufses AH Jr. Differences in pathogenesis, incidence and outcome of perforation in inflammatory bowel disease. Surg Gynecol Obstet. 1985;160:63–69.PubMed
4.
go back to reference Greenstein AJ, Mann D, Sachar DB, Aufses AH Jr. Free perforation in Crohn’s disease: I. A survey of 99 cases. Am J Gastroenterol. 1985;80:682–689.PubMed Greenstein AJ, Mann D, Sachar DB, Aufses AH Jr. Free perforation in Crohn’s disease: I. A survey of 99 cases. Am J Gastroenterol. 1985;80:682–689.PubMed
5.
go back to reference Greenstein AJ, Sachar DB, Mann D, Lachman P, Heimann T, Aufses AH Jr. Spontaneous free perforation and perforated abscess in 30 patients with Crohn’s disease. Ann Surg. 1987;205:72–76.CrossRefPubMedPubMedCentral Greenstein AJ, Sachar DB, Mann D, Lachman P, Heimann T, Aufses AH Jr. Spontaneous free perforation and perforated abscess in 30 patients with Crohn’s disease. Ann Surg. 1987;205:72–76.CrossRefPubMedPubMedCentral
6.
go back to reference Eshuis EJ, Griffioen GH, Stokkers PC, Ubbink DT, Bemelman WA. Anti tumour necrosis factor as risk factor for free perforations in Crohn’s disease? A case–control study. Colorectal Dis. 2012;14:578–584.CrossRefPubMed Eshuis EJ, Griffioen GH, Stokkers PC, Ubbink DT, Bemelman WA. Anti tumour necrosis factor as risk factor for free perforations in Crohn’s disease? A case–control study. Colorectal Dis. 2012;14:578–584.CrossRefPubMed
7.
go back to reference Ikeuchi H, Yamamura T. Free perforation in Crohn’s disease: review of the Japanese literature. J Gastroenterol. 2002;37:1020–1027.CrossRefPubMed Ikeuchi H, Yamamura T. Free perforation in Crohn’s disease: review of the Japanese literature. J Gastroenterol. 2002;37:1020–1027.CrossRefPubMed
8.
go back to reference Doh YS, Kim YS, Bae SI, et al. The clinical characteristics of patients with free perforation in Korean Crohn’s disease: results from the CONNECT study. BMC Gastroenterol. 2015;15:31.CrossRefPubMedPubMedCentral Doh YS, Kim YS, Bae SI, et al. The clinical characteristics of patients with free perforation in Korean Crohn’s disease: results from the CONNECT study. BMC Gastroenterol. 2015;15:31.CrossRefPubMedPubMedCentral
9.
go back to reference Bundred NJ, Dixon JM, Lumsden AB, Gilmour HM, Davies GC. Free perforation in Crohn’s colitis. A ten-year review. Dis Colon Rectum. 1985;28:35–37.CrossRefPubMed Bundred NJ, Dixon JM, Lumsden AB, Gilmour HM, Davies GC. Free perforation in Crohn’s colitis. A ten-year review. Dis Colon Rectum. 1985;28:35–37.CrossRefPubMed
11.
go back to reference Orda R, Goldwaser B, Wiznitzer T. Free perforation of the colon in Crohn’s disease: report of a case and review of the literature. Dis Colon Rectum. 1982;25:145–147.CrossRefPubMed Orda R, Goldwaser B, Wiznitzer T. Free perforation of the colon in Crohn’s disease: report of a case and review of the literature. Dis Colon Rectum. 1982;25:145–147.CrossRefPubMed
12.
go back to reference Lee YJ, Yang SK, Byeon JS, et al. Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn’s disease. Endoscopy. 2006;38:592–597.CrossRefPubMed Lee YJ, Yang SK, Byeon JS, et al. Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn’s disease. Endoscopy. 2006;38:592–597.CrossRefPubMed
13.
go back to reference Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn’s disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology. 1998;114:1161–1168.CrossRefPubMed Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn’s disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology. 1998;114:1161–1168.CrossRefPubMed
14.
go back to reference Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study. Inflamm Bowel Dis. 2008;14:542–549.CrossRefPubMed Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study. Inflamm Bowel Dis. 2008;14:542–549.CrossRefPubMed
15.
go back to reference Park SH, Yang SK, Park SK, et al. Long-term prognosis of Crohn’s disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea. Inflamm Bowel Dis. 2014;20:488–494.CrossRefPubMed Park SH, Yang SK, Park SK, et al. Long-term prognosis of Crohn’s disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea. Inflamm Bowel Dis. 2014;20:488–494.CrossRefPubMed
16.
go back to reference Colombel JF, Loftus EV Jr, Tremaine WJ, et al. Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol. 2004;99:878–883.CrossRefPubMed Colombel JF, Loftus EV Jr, Tremaine WJ, et al. Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol. 2004;99:878–883.CrossRefPubMed
17.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–349.CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–349.CrossRef
18.
go back to reference Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A–36A.CrossRefPubMed Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A–36A.CrossRefPubMed
21.
go back to reference Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8–15.CrossRefPubMed Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8–15.CrossRefPubMed
22.
go back to reference Werbin N, Haddad R, Greenberg R, Karin E, Skornick Y. Free perforation in Crohn's disease. Isr Med Assoc J. 2003;5:175–177. Werbin N, Haddad R, Greenberg R, Karin E, Skornick Y. Free perforation in Crohn's disease. Isr Med Assoc J. 2003;5:175–177.
Metadata
Title
Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn’s Disease
Authors
Jong Wook Kim
Ho-Su Lee
Byong Duk Ye
Suk-Kyun Yang
Sung Wook Hwang
Sang Hyoung Park
Dong-Hoon Yang
Kyung-Jo Kim
Jeong-Sik Byeon
Seung-Jae Myung
Yong Sik Yoon
Chang Sik Yu
Jin-Ho Kim
Publication date
01-06-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4539-5

Other articles of this Issue 6/2017

Digestive Diseases and Sciences 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.